University of Michigan

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).

1,327 total trials 179 currently recruiting 971 completed early-phase tilt top decile by trial count

University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.

University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.

Top-decile sponsor footprint

University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,327 total, page 8 of 27

COMPLETED NA

DeADT - Living Well With Prostate Cancer

NCT06199986

COMPLETED NA

Prescribing Vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients with Postoperative Pain:

NCT05370404

COMPLETED NA

Acupressure in Rheumatoid Arthritis

NCT05412121

COMPLETED NA

Effect of Peripheral Neuromodulation on Vaginal Blood Flow - Study 2

NCT06999265

COMPLETED NA

Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis

NCT05362578

COMPLETED NA

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2

NCT05345184

COMPLETED NA

The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps

NCT05457322

COMPLETED Phase 2

Ultrasonic Deep Brain Stimulation During Anesthetic Sedation

NCT05495945

COMPLETED Phase 4

A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery

NCT05441592

COMPLETED NA

LowSalt4Life: A Mobile Application to Reduce Sodium Intake And Blood Pressure

NCT05396001

COMPLETED NA

A Scalable Model for Promoting Functioning and Well-Being Among Veterans With a History of Mental Health Challenges Via Meaningful Social Interactions: Project V-SPEAK!

NCT05506839

COMPLETED

Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

NCT05700006

COMPLETED NA

Intern Health Study 2022 and 2023

NCT05436145

COMPLETED NA

Knowledge Translation Intervention for ACL Injury Prevention Program in Youth Soccer

NCT05442879

COMPLETED NA

What is the Optimal Technique for Hydrodistention?

NCT05456308

COMPLETED NA

A Single Group Study of Empower@Home-an Internet Cognitive Behavioral Therapy Intervention

NCT05384704

COMPLETED NA

Behavioral Economic Treatment to Enhance Rural (BETTER) Living

NCT05235971

TERMINATED NA

Memory Training and Neural Plasticity

NCT05380739

COMPLETED NA

Speech Processing in Stuttering

NCT04929184

COMPLETED NA

Human Algorithm Interactions for Acute Respiratory Failure Diagnosis

NCT06098950

COMPLETED NA

The Lifestyle Education About Nutrition for Diabetes (Legend) Study

NCT05237128

COMPLETED NA

Longitudinal Monitoring of Microsurgical Socket Augmentation Healing With Ultrasonography

NCT05297071

COMPLETED Phase 4

Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

NCT05212610

COMPLETED NA

The Lifestyle Education About Prediabetes (Leap) Study

NCT05235425

COMPLETED NA

Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing

NCT04776928

COMPLETED

Device for Age-related Macular Degeneration (AMD)

NCT06178978

COMPLETED

Point of Care, High Resolution and 3-Dimensional Ultrasonography

NCT05282212

COMPLETED NA

Empower@Home: A Feasibility Pilot

NCT05243264

COMPLETED Phase 4

Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma

NCT05036733

COMPLETED NA

Brain State-dependent Stimulation to Improve Movement

NCT05103176

COMPLETED NA

Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship Trial

NCT05176353

COMPLETED NA

Three Instructional Interventions for Prehospital Cervical Spinal Immobilization by Laypeople

NCT05359575

COMPLETED

Hemodynamic Changes During Implant Surgery with Intravenous Conscious Sedation

NCT05756439

COMPLETED NA

Pediatric Early Autism Recognition System: PEARS

NCT05153551

COMPLETED NA

Project IntERact V2

NCT05109325

COMPLETED NA

Motivating Individuals With Lupus to Exercise

NCT05287581

COMPLETED NA

sipIT2: Improving Adherence to Fluid Intake Guidelines for Kidney Stone Prevention

NCT05196113

COMPLETED NA

Improving Blood Pressure Control Through the myBPmyLife mHealth Application

NCT05154929

COMPLETED NA

Skeletal Muscle and Adipose Tissue Responses After Acute Exercise: Comparing Effects of Three Different Intensities

NCT05365334

TERMINATED NA

Virtual Reality Decreases Child Anxiety and Pain as Well as Caregiver Anxiety and Pain Perception During Orthopaedic Clinic Office Procedures

NCT05708586

COMPLETED Phase 2

Contrast Enhanced Ultrasound for Renal Obstruction

NCT05090800

COMPLETED NA

Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES)

NCT05026710

COMPLETED NA

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT05022641

COMPLETED NA

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

NCT05022667

COMPLETED Phase 2

A Trial to Improve Quality of Life in People With Cirrhosis

NCT05061992

COMPLETED NA

Developing Text-based Support for Parents of Adolescents After an Emergency Department Visit

NCT05058664

COMPLETED NA

Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson Disease

NCT05446194

COMPLETED NA

Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial

NCT05085405

COMPLETED NA

Healthy Lifetime - Sustainability and Quality Study

NCT05071326

COMPLETED NA

The "Open Wound Bone Augmentation Concept" with Amnion-Chorion Membrane

NCT05013580

← Previous Page 8 of 27 Next →

Phase Distribution

PhaseTrial count
Phase 1 79
Phase 2 80
Phase 3 25
Phase 4 69

What is open in the University of Michigan pipeline

179 recruiting of 1,327 indexed (13% open); 971 completed (73%).

Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).

Top condition: Depression (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Michigan: open-pipeline peers nationwide

Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share University of MichiganEli Lilly and CompanyGlaxoSmithKlineAstraZenecaUniversity of Colorado, DenverWayne State UniversityCase Comprehensive Cancer CenterAlbany Medical CollegeTaiho Oncology
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,327 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Michigan page

1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.

  • 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.